China Universal Asset Management Co., Ltd. Astrazeneca PLC Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 149,796 shares of AZN stock, worth $11.4 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
149,796
Previous 119,382
25.48%
Holding current value
$11.4 Million
Previous $9.3 Million
5.5%
% of portfolio
0.95%
Previous 1.04%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.61 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.13 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.86 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.83 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.83 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $237B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...